John Sandlund, MD

John T. Sandlund, MD

Member, St. Jude Faculty
Medical Director, Leukemia / Lymphoma Clinic
Medical Director, Russia Program - International Outreach

Departments

Oncology

Divisions

Leukemia / Lymphoma

Contact Information

John Sandlund, MD
Oncology
Leukemia / Lymphoma
MS 260, Room C-6063
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: john.sandlund@stjude.org
Phone: (901) 595-2427
FAX: (901) 521-9005

Education

MD - Ohio State University College of Medicine, Columbus, OH


Research Interests

  • The non-Hodgkin lymphomas
  • c-Myc regulation in Burkitt lymphoma
  • Acute leukemias

Selected Publications

Sandlund JT. Clinical features and treatment approaches for the uncommon non-Hodgkin lymphoma subtypes of childhood. ASCO educational session: Challenging lymphomas in pediatrics (Sandlund JT, chair). 2009 (in press).

Pui C-H, Campana D, Deqing P, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Downing JR, Evans WE, Relling MV. New England Journal of Medicine 2009 (in press).

Coustan-Smith E, Sandlund JT, Perkins SL, Chen H, Chang M, Abromowitch M, Campana D. Minimal residual disease detection in childhood T-cell lymphoblastic lymphoma: a children’s oncology group study. Journal of Clinical Oncology 2009 (in press).

Jeha S, Pei D, Raimondi SC, Onciu M, Campana D, Cheng C, Sandlund JT, Ribeiro RC, Rubnitz JE, Howard  SC, Downing JR, Evans WE, Relling MV, Pui C-H. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia 2009 (epub ahead of print).

Sandlund JT, Pui C-H, Zhou Y, Behm FG, Onciu M, Razzouk BI, Hijiya N, Campana D, Hudson MM, Ribeiro RC. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia 2009 (epub ahead of print).

Roberson JR, Spraker HL, Shelso J, Zhou Y, Inaba H, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Pui C-H, Howard SC: Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia. Leukemia 23: 245-250, 2009.

Sandlund JT. The Combination of Monoclonal Antibodies and Conventional Chemotherapy for Children with Malignant Lymphoma:  Opportunities and Challenges. Pediatric Blood and Cancer (Highlight) Feb;52(2):150-2, 2009.

Sandlund JT, Santana VM, Hudson MM, Onciu M, Behm FG, Head D, Murry DJ, Ribeiro R, Wallace D, Rencher R, Pui C-H. Dexamethasone, High-dose Cytarabine and Carboplatin (DAC) Combination is Effective for Childhood Advanced Large Large Cell Non-Hodgkin Lymphoma. Cancer 113: 782-790, 2008.

Ribeiro RC, Sandlund JT. Burkitt Lymphoma in African Children: A Priority for the Global Health Agenda. Pediatric Blood and Cancer (Highlight) 50: 1125-1126, 2008.

Sandlund JT. Should adolescents with NHL be treated as old children or young adults? Hematology Am Soc Hematol Educ Program 2007:297-303, 2007.

Anghelescu D, Burgoyne L, Liu T, Li CS, Pui CH, Hudson M, Furman W, Sandlund JT. Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Pediatric Anesthesia 17:1090-1098, 2007.

Gupta H, Davidoff A, Pui C-H, Shochat S, Sandlund J. Clinical implications and surgical management of intussusception in pediatric patients with Burkitt lymphoma. J Pediatr Surg 42:998-1001, 2007.

Hijiya N, Hudson M, Lensing S, Zacher M, Onciu M, Behm F, Razzouk B, Ribeiro R, Rubnitz J, Sandlund J, Rivera G, Evans W, Relling M, Pui C-H. Cumulative incidence of secondary neoplasms as the first event after treatment of childhood acute lymphoblastic leukemia increases over 30 years. JAMA 297:1207-1215, 2007.

Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152-159, 2007.

Jeha S, Behm F, Pei D, Sandlund JT, Ribeiro RC, Razzouk BI, Rubnitz JE, Hijiya N, Howard SC, Cheng C, Pui CH. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia. Blood 108:3302-3304, 2006.

Hijiya N, Panetta JC, Zhou Y, Kyzer EP, Howard SC, Jeha S, Razzouk BI, Ribeiro RC, Rubnitz JE, Hudson MM, Sandlund JT, Pui CH, Relling MV. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 108:3997-4002, 2006.

Onciu M, Schlette E, Zhou Y, Raimondi SC, Giles FJ, Kantarjian HM, Medeiros LJ, Ribeiro RC, Pui CH, Sandlund JT. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma. Cancer 107:1084-1092, 2006.

Pui C-H, Pei D, Sandlund JT, Evans WE, Relling MV. Central-nervous-systemic-directed treatment in childhood acute lymphoblastic leukemia. Ann Hematol 85:91-92, 2006. Acute Leukemias XI meeting in Munich, Germany in 2006.

Pui C-H, Relling MV, Sandlund JT, Downing JR, Campana D, Evans WE. Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia: Study design and preliminary results. Ann Hematol 85:88-91, 2006. Acute Leukemias XI meeting in Munich, Germany in 2006.

Sandlund JT, Kastan MB, Kennedy W, Behm F, Entrekin E, Pui CH, Kalwinsky DT, Raimondi SC. A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia. Cancer Genet Cytogenet 168:69-72, 2006.

Hendrick JM, Kaste SC, Tamburro RF, Hoffer FA, Onciu M, Sandlund JT, Ribeiro RC, Chandler JC, Howard SC. Abdominal compartment syndrome in a newly diagnosed patient with Burkitt lymphoma. Pediatr Radiol 36:254-257, 2006.

Abla O, Sandlund JT, Sung L, Brock P, Corbett R, Kirov I, Griffin TC, Blaser S, Weitzman S. A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation. Pediatr Blood Cancer 47:880-885, 2006.

Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng C, Downing JR, Evans WE, Relling MV, Hudson M. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:7936-7941, 2005.

Sanders RP, Maddirala SD, Geiger TL, Pounds S, Sandlund JT, Ribeiro RC, Pui CH, Howard SC. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 130:781-787, 2005.

McCarville MB, Adelman CS, Li C, Xiong X, Furman WL, Razzouk BI, Pui CH, Sandlund JT. Typhlitis in childhood cancer. Cancer 104:380-387, 2005.

Hijiya N, Liu W, Sandlund JT, Jeha S, Razzouk BI, Ribeiro RC, Rubnitz JE, Howard SC, Kyzer EP, Redd DS, Cheng C, Rivera GK, Hudson MM, Relling MV, Pui CH. Overt testicular disease at diagnosis of childhood acute lymphoblastic leukemia: lack of therapeutic role of local irradiation. Leukemia 19:1399-1403, 2005.

Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, Sandlund JT, Rubnitz J, Ribeiro R, Campana D, Pui CH, Evans WE, Relling MV. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105:4752-4758, 2005.

Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer 45:10-15, 2005.

Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer 103:368-376, 2005.

Last update: June 2009

Email This Article Email This Article   |   Print Print